New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Reports First Quarter 2020 Financial Results | Business Wire
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
News & Media
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Jury holds drugmaker Teva liable in opioid crisis | WLUK
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
Teva enters opioid settlement agreement with US state Rhode Island
Smart Inhalers Market See Huge Growth for New Norm Featuring Teva
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva shed 37% of Israel workforce in two years - Globes
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Global Biosimilar Hormones Market 2021, Industry Trends,
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited (TEVA) - Faruqi & Faruqi LLP
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
